The robots are coming to medtech: Where’s the value?

By

The robots are coming to medtech: Where’s the value? (Medical Design & Outsourcing)

As each medtech manufacturer gears up to bring robots to surgery, they’ll need to create an outcomes-oriented value story in order to compete.
The biggest medtech headlines so far in 2019 tell a consistent story: The robots are coming.
From Medtronic’s $1.6 billion acquisition of Mazor in late December to Johnson & Johnson dropping $3.4 billion to acquire Auris Health in the first quarter, many major players are making significant investments in robotics. T
The robot-assisted surgery market...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.